GlassScriptPhysician profile
Charles Michael Lombard
NPI 1720164775
$840.38
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $64.30 · 2023: $21.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Broncus Medical | $250.00 | 2019 | |
| Boston Scientific Corporation | $216.34 | 2019 | |
| Novartis Pharmaceuticals Corporation | $130.15 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $78.83 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.41 | 2019 | |
| Blueprint Medicines Corporation | $24.97 | 2020 | |
| Hologic Sales and Service, LLC | $21.18 | 2023 | Trident Specimen Radiography System, Panther Fusion |
| Celgene Corporation | $17.66 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.96 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Lombard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.